Protein becomes even more important during and after GLP-1 treatment
The Obesity Pathway Innovation Programme funded by government and weight-loss drug manufacturer Eli Lilly to test methods of offering weight management services across the UK is expected to include some community pharmacies
J Cell Physiol (2015) 230(12):300918.10.1002/jcp.25033 19 MieczkowskaAMansurSBouvardBFlattPRThorensBIrwinNet alDouble incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength
GLP-1 receptors are found in the brain, and GLP-1 signaling may influence appetite, glucose regulation, inflammation, vascular function, and possibly neuronal stress pathways
A 50-year-old may respond more dramatically to CJC-1295/Ipamorelin than a 25-year-old because the baseline is lower
Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study